Literature DB >> 32556962

ATP10B and the risk for Parkinson's disease.

Raquel Real1,2, Anni Moore3, Cornelis Blauwendraat3, Huw R Morris1,2, Sara Bandres-Ciga4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32556962      PMCID： PMC7540943          DOI： 10.1007/s00401-020-02172-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  1 in total

1.  Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme.

Authors:  Michael L Alosco; Jonathan D Cherry; Bertrand Russell Huber; Yorghos Tripodis; Zachary Baucom; Neil W Kowall; Nicole Saltiel; Lee E Goldstein; Douglas I Katz; Brigid Dwyer; Daniel H Daneshvar; Joseph N Palmisano; Brett Martin; Robert C Cantu; Robert A Stern; Victor E Alvarez; Jesse Mez; Thor D Stein; Ann C McKee
Journal:  Acta Neuropathol       Date:  2020-08-11       Impact factor: 17.088
  1 in total
  3 in total

1.  ATP10B variants in Parkinson's disease: a large cohort study in Chinese mainland population.

Authors:  Yuwen Zhao; Hongxu Pan; Yige Wang; Qian Zeng; Zhenghuan Fang; Runcheng He; Kun Xu; Xiaoxia Zhou; Xun Zhou; Zhou Zhou; Yanghong Li; Penghui Deng; Yinghui Xu; Qian Xu; Qiying Sun; Bin Li; Guihu Zhao; Lifang Lei; Hainan Zhang; Chunyu Wang; Jieqiong Tan; Xinxiang Yan; Lu Shen; Hong Jiang; Jinchen Li; Jifeng Guo; Beisha Tang; Zhenhua Liu
Journal:  Acta Neuropathol       Date:  2021-02-18       Impact factor: 17.088

2.  Reply: ATP10B variants in Parkinson's disease-a large cohort study in Chinese mainland population.

Authors:  Stefanie Smolders; Christine Van Broeckhoven
Journal:  Acta Neuropathol       Date:  2021-02-18       Impact factor: 17.088

Review 3.  Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.

Authors:  Martin Lang; Peter P Pramstaller; Irene Pichler
Journal:  Mol Neurodegener       Date:  2022-07-16       Impact factor: 18.879
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.